Christopher E. Kevane - 08 Dec 2023 Form 4 Insider Report for UNIVERSAL TECHNICAL INSTITUTE INC (UTI)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Dec 2023, 09:16:56 UTC
Prior SEC filing
06 Mar 2023
Next SEC filing
18 Dec 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher E. Kevane

Key filing fact

Christopher E. Kevane filed Form 4 for UNIVERSAL TECHNICAL INSTITUTE INC (UTI) on 13 Dec 2023.

Key facts

  • This page summarizes Christopher E. Kevane's Form 4 filing for UNIVERSAL TECHNICAL INSTITUTE INC (UTI).
  • 11 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 13 Dec 2023, 09:16.

Change

  • Previous filing in this sequence was filed on 06 Mar 2023.
  • Current net transaction value: -$73,407.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTI transaction

Common Stock, $0.0001 par value

Options Exercise

Transaction value
Shares
+6,460
Change %
+29%
Price
Shares after
28,378
Date
08 Dec 2023
Ownership
Direct
Footnotes
F1
UTI transaction

Common Stock, $0.0001 par value

Tax liability

Transaction value
$21,384
Shares
-1,800
Change %
-6.3%
Price
$11.88
Shares after
26,578
Date
08 Dec 2023
Ownership
Direct
Footnotes
F2
UTI transaction

Common Stock, $0.0001 par value

Options Exercise

Transaction value
Shares
+8,460
Change %
+32%
Price
Shares after
35,038
Date
08 Dec 2023
Ownership
Direct
Footnotes
F1
UTI transaction

Common Stock, $0.0001 par value

Tax liability

Transaction value
$28,001
Shares
-2,357
Change %
-6.7%
Price
$11.88
Shares after
32,681
Date
08 Dec 2023
Ownership
Direct
Footnotes
F3
UTI transaction

Common Stock, $0.0001 par value

Options Exercise

Transaction value
Shares
+7,260
Change %
+22%
Price
Shares after
39,941
Date
10 Dec 2023
Ownership
Direct
Footnotes
F1
UTI transaction

Common Stock, $0.0001 par value

Tax liability

Transaction value
$24,021
Shares
-2,022
Change %
-5.1%
Price
$11.88
Shares after
37,919
Date
10 Dec 2023
Ownership
Direct
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UTI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-6,460
Change %
-50%
Price
$0.000000
Shares after
6,460
Date
08 Dec 2023
Ownership
Direct
Underlying class
Common Stock, $0.0001 par value
Underlying amount
6,460
Exercise price
Footnotes
F1, F5
UTI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-8,460
Change %
-33%
Price
$0.000000
Shares after
16,921
Date
08 Dec 2023
Ownership
Direct
Underlying class
Common Stock, $0.0001 par value
Underlying amount
8,460
Exercise price
Footnotes
F1, F6
UTI transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+17,790
Change %
Price
$0.000000
Shares after
17,790
Date
08 Dec 2023
Ownership
Direct
Underlying class
Common Stock, $0.0001 par value
Underlying amount
17,790
Exercise price
Footnotes
F7
UTI transaction Derivative

Performance Units

Award

Transaction value
$0
Shares
+33,357
Change %
Price
$0.000000
Shares after
33,357
Date
08 Dec 2023
Ownership
Direct
Underlying class
Common Stock, $0.0001 par value
Underlying amount
33,357
Exercise price
Footnotes
F8
UTI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-7,260
Change %
-100%
Price
$0.000000*
Shares after
0
Date
10 Dec 2023
Ownership
Direct
Underlying class
Common Stock, $0.0001 par value
Underlying amount
7,260
Exercise price
Footnotes
F1, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of UTI Common Stock.

Footnote F2

Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/08/2021.

Footnote F3

Shares withheld to satisfy tax liability for the vesting of restricted stock units granted on 12/8/2022.

Footnote F4

Shares withheld to satisfy tax liability for the vesting of performance units granted on 12/10/2020.

Footnote F5

Share of Common Stock received from vesting of restricted stock units granted on 12/08/2021.

Footnote F6

Vesting of restricted stock units granted on 12/08/2022.

Footnote F7

The restricted stock units vest in three equal installments beginning on December 8, 2024.

Footnote F8

Each performance unit represents a contingent right to receive one share of the UTI Common Stock, 60% of which vest based on revenue for the fiscal year ending September 30, 2026 and 40% of which vest based on adjusted EBITDA for the fiscal year ending September 30, 2026.

Footnote F9

Shares of Common Stock received from vesting of performance units granted on 12/10/2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .